147 related articles for article (PubMed ID: 13224672)
1. Serum accelerator factors and antihemophilic factor (AHF) in early phases of clotting.
GRAHAM JB; LANGDELL RD; MORRISON FC; BRINKHOUS KM
Proc Soc Exp Biol Med; 1954 Oct; 87(1):45-8. PubMed ID: 13224672
[No Abstract] [Full Text] [Related]
2. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
[No Abstract] [Full Text] [Related]
3. [The consumption of antihemophilic globulin and the development of thromboplastin accelerator power in the adsorbed plasma-recalcified serum mixture. The problem of the responsible serum substrate].
MAYER G; MAYER S; WAITZ R
Rev Fr Etud Clin Biol; 1961 Nov; 6():924-8. PubMed ID: 14471688
[No Abstract] [Full Text] [Related]
4. Plasma antihemophilic factor biological and clinical aspects.
BRINKHOUS KM
Sang; 1954; 25(7):738-41. PubMed ID: 13225559
[No Abstract] [Full Text] [Related]
5. Antihemophilic factor (AHF) levels following transfusions of blood, plasma and plasma fractions.
LANGDELL RD; WAGNER RH; BRINKHOUS KM
Proc Soc Exp Biol Med; 1955 Feb; 88(2):212-5. PubMed ID: 14357391
[No Abstract] [Full Text] [Related]
6. STUDIES OF THE ANTIHEMOPHILIC FACTOR (AHF, FACTOR VIII) PRODUCED IN VON WILLEBRAND'S DISEASE.
BARROW EM; ROBERTS HR; PONS K; GRAHAM JB
Proc Soc Exp Biol Med; 1964 Mar; 115():760-3. PubMed ID: 14155821
[No Abstract] [Full Text] [Related]
7. [Does lyophilization cause the appearance of a non-specific thromboplastic activity in the blood? Study of the antihemophilic factors A and B].
DUCOS J; BIERME R
C R Seances Soc Biol Fil; 1960; 154():808-12. PubMed ID: 13724735
[No Abstract] [Full Text] [Related]
8. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.
BRECKENRIDGE RT; RATNOFF CD
Blood; 1962 Aug; 20():137-49. PubMed ID: 13872719
[No Abstract] [Full Text] [Related]
9. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
Guimbretére J
Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
[No Abstract] [Full Text] [Related]
10. Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.
SEEGERS WH; LANDABURU RH; HOLBURN RR; TOCANTINS LM
Proc Soc Exp Biol Med; 1957 Jul; 95(3):583-5. PubMed ID: 13453515
[No Abstract] [Full Text] [Related]
11. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
Uszyński L
Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
[No Abstract] [Full Text] [Related]
12. Familial association of thrombopathia and antihemophilic factor (AHF, factor VIII) deficiency.
Crowell EB; Eisner EV
Blood; 1972 Aug; 40(2):227-33. PubMed ID: 4537881
[No Abstract] [Full Text] [Related]
13. Immunologic studies of antihemophilic factor (AHF, factor VIII). 3. Comparative binding properties of human and rabbit anti-AHF.
Hoyer LW
Blood; 1972 Apr; 39(4):481-9. PubMed ID: 4622205
[No Abstract] [Full Text] [Related]
14. Bleeding time after aspirin in disorders of intrinsic clotting.
Kaneshiro MM; Mielke CH; Kasper CK; Rapaport SI
N Engl J Med; 1969 Nov; 281(19):1039-42. PubMed ID: 5307310
[No Abstract] [Full Text] [Related]
15. Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.
Weiss HJ; Hoyer IW
Science; 1973 Dec; 182(4117):1149-51. PubMed ID: 4127287
[TBL] [Abstract][Full Text] [Related]
16. The substructure of antihemophilic factor (AHF, factor VIII): some clearing of the fog.
Ratnoff OD
J Lab Clin Med; 1977 Jun; 89(6):1159-62. PubMed ID: 301159
[No Abstract] [Full Text] [Related]
17. ANTIHEMOPHILIC FACTOR LEVELS IN BLEEDER SWINE FOLLOWING INFUSIONS OF PLASMA AND SERUM.
MUHRER ME; LECHLER E; CORNELL CN; KIRKLAND JL
Am J Physiol; 1965 Mar; 208():508-10. PubMed ID: 14264742
[No Abstract] [Full Text] [Related]
18. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
19. [Hemophilia A with presence in the serum of a specific inhibitor of antihemophilic B globulin].
STEFANOVIC S; ROLOVIC Z; BOZINOVIC L
Hemostase; 1961 Jun; 1():135-41. PubMed ID: 13916528
[No Abstract] [Full Text] [Related]
20. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
McPherson J; Soberano ME; Macdonald C; Zucker MB
Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
